The Trump Administration is in discussions with Eli Lilly and Company and Novo Nordisk A/S to sell low-dose versions of their popular weight-loss drugs for $149 per month through TrumpRx, the Wall Street Journal reported on Tuesday. The plan would also expand Medicare and Medicaid coverage for the medications, according to the people familiar with the matter.
If finalized, Trump will probably announce the deals on Thursday at the White House, joined by pharmaceutical executives. The arrangement would cover drugs such as Novo Nordisk's Wegovy and Lilly's Zepbound, while Lilly's experimental pill orforglipron could be added if approved by the Food and Drug Administration (FDA).
The talks are part of the administration's broader effort to reduce US drug prices under its "most favored nation" initiative, following similar agreements already reached with Pfizer Inc. and AstraZeneca.
https://breakingthenews.net/Article/Trump-admin-seeks-dollar149-weight-loss-drug-deal/65117230
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.